APO Research
Talk to an analyst

APO RESEARCH · REPORT

EGFR-TKI

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global EGFR-TKI Market Analysis and Forecast 2026-2032

27 December 2025200 pages

Choose your research edition.

Industry ResearchEGFR-TKI Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal EGFR-TKI Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal EGFR-TKI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EGFR-TKI Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal EGFR-TKI Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global EGFR-TKI market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for EGFR-TKI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for EGFR-TKI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for EGFR-TKI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for EGFR-TKI is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of EGFR-TKI include ArriVent Biopharma, AstraZeneca, Beacon Pharma, Boehringer Ingelheim Pharmaceuticals, Cipla, Drug International, Glenmark Pharmaceuticals, Hanmi Pharmaceutical and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for EGFR-TKI, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of EGFR-TKI, also provides the sales of main regions and countries. Of the upcoming market potential for EGFR-TKI, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the EGFR-TKI sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global EGFR-TKI market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for EGFR-TKI sales, projected growth trends, production technology, application and end-user industry.

EGFR-TKI Segment by Company

ArriVent Biopharma

AstraZeneca

Beacon Pharma

Boehringer Ingelheim Pharmaceuticals

Cipla

Drug International

Glenmark Pharmaceuticals

Hanmi Pharmaceutical

Johnson & Johnson

Mylan

Pfizer

Roche

Teva

Yuhan Corporation

Betta Pharma

Chengdu Brilliant Pharmaceuticals

Hansoh Pharma

Shanghai Allist Pharmaceuticals

Wanbang Biopharmaceuticals

EGFR-TKI Segment by Type

Afatinib

Aumolertinib

Icotinib

Osimertinib

Dacomitinib

Erlotinib

Furmonertinib

Gefitinib

Lazertinib

Other

EGFR-TKI Segment by Application

Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

EGFR-TKI Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EGFR-TKI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EGFR-TKI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EGFR-TKI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of EGFR-TKI in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of EGFR-TKI manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EGFR-TKI sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global EGFR-TKI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Afatinib Major Manufacturers Table 3. Aumolertinib Major Manufacturers Table 4. Icotinib Major Manufacturers Table 5. Osimertinib Major Manufacturers Table 6. Dacomitinib Major Manufacturers Table 7. Erlotinib Major Manufacturers Table 8. Furmonertinib Major Manufacturers Table 9. Gefitinib Major Manufacturers Table 10. Lazertinib Major Manufacturers Table 11. Other Major Manufacturers Table 12. Global EGFR-TKI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 13. Segment by Application Major Manufacturers Table 14. Hospital and Clinic Major Manufacturers Table 15. Retail Pharmacies Major Manufacturers Table 16. Other Major Manufacturers Table 17. EGFR-TKI Industry Trends Table 18. EGFR-TKI Industry Drivers Table 19. EGFR-TKI Industry Opportunities and Challenges Table 20. EGFR-TKI Industry Restraints Table 21. Global EGFR-TKI Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global EGFR-TKI Revenue by Region (2021-2026) & (US$ Million) Table 23. Global EGFR-TKI Revenue by Region (2027-2032) & (US$ Million) Table 24. Global EGFR-TKI Revenue Market Share by Region (2021-2026) Table 25. Global EGFR-TKI Revenue Market Share by Region (2027-2032) Table 26. Global EGFR-TKI Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 27. Global EGFR-TKI Sales by Region (2021-2026) & (K Units) Table 28. Global EGFR-TKI Sales by Region (2027-2032) & (K Units) Table 29. Global EGFR-TKI Sales Market Share by Region (2021-2026) Table 30. Global EGFR-TKI Sales Market Share by Region (2027-2032) Table 31. Global EGFR-TKI Revenue by Manufacturers (US$ Million) & (2021-2026) Table 32. Global EGFR-TKI Revenue Market Share by Manufacturers (2021-2026) Table 33. Global EGFR-TKI Sales by Manufacturers (US$ Million) & (2021-2026) Table 34. Global EGFR-TKI Sales Market Share by Manufacturers (2021-2026) Table 35. Global EGFR-TKI Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 36. Global EGFR-TKI Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 37. Global EGFR-TKI Key Manufacturers Manufacturing Sites & Headquarters Table 38. Global EGFR-TKI Manufacturers, Product Type & Application Table 39. Global EGFR-TKI Manufacturers' Establishment Date Table 40. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 41. Global EGFR-TKI by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global EGFR-TKI Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 44. Global EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 45. Global EGFR-TKI Revenue Market Share by Type (2021-2026) Table 46. Global EGFR-TKI Revenue Market Share by Type (2027-2032) Table 47. Global EGFR-TKI Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 48. Global EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 49. Global EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 50. Global EGFR-TKI Sales Market Share by Type (2021-2026) Table 51. Global EGFR-TKI Sales Market Share by Type (2027-2032) Table 52. Global EGFR-TKI Price by Type (2021-2026) & (US$/Unit) Table 53. Global EGFR-TKI Price by Type (2027-2032) & (US$/Unit) Table 54. Global EGFR-TKI Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 56. Global EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 57. Global EGFR-TKI Revenue Market Share by Application (2021-2026) Table 58. Global EGFR-TKI Revenue Market Share by Application (2027-2032) Table 59. Global EGFR-TKI Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 60. Global EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 61. Global EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 62. Global EGFR-TKI Sales Market Share by Application (2021-2026) Table 63. Global EGFR-TKI Sales Market Share by Application (2027-2032) Table 64. Global EGFR-TKI Price by Application (2021-2026) & (US$/Unit) Table 65. Global EGFR-TKI Price by Application (2027-2032) & (US$/Unit) Table 66. ArriVent Biopharma Company Information Table 67. ArriVent Biopharma Business Overview Table 68. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. ArriVent Biopharma EGFR-TKI Product Portfolio Table 70. ArriVent Biopharma Recent Development Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca EGFR-TKI Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Beacon Pharma Company Information Table 77. Beacon Pharma Business Overview Table 78. Beacon Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Beacon Pharma EGFR-TKI Product Portfolio Table 80. Beacon Pharma Recent Development Table 81. Boehringer Ingelheim Pharmaceuticals Company Information Table 82. Boehringer Ingelheim Pharmaceuticals Business Overview Table 83. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio Table 85. Boehringer Ingelheim Pharmaceuticals Recent Development Table 86. Cipla Company Information Table 87. Cipla Business Overview Table 88. Cipla EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Cipla EGFR-TKI Product Portfolio Table 90. Cipla Recent Development Table 91. Drug International Company Information Table 92. Drug International Business Overview Table 93. Drug International EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Drug International EGFR-TKI Product Portfolio Table 95. Drug International Recent Development Table 96. Glenmark Pharmaceuticals Company Information Table 97. Glenmark Pharmaceuticals Business Overview Table 98. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Glenmark Pharmaceuticals EGFR-TKI Product Portfolio Table 100. Glenmark Pharmaceuticals Recent Development Table 101. Hanmi Pharmaceutical Company Information Table 102. Hanmi Pharmaceutical Business Overview Table 103. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hanmi Pharmaceutical EGFR-TKI Product Portfolio Table 105. Hanmi Pharmaceutical Recent Development Table 106. Johnson & Johnson Company Information Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Johnson & Johnson EGFR-TKI Product Portfolio Table 110. Johnson & Johnson Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan EGFR-TKI Product Portfolio Table 115. Mylan Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Pfizer EGFR-TKI Product Portfolio Table 120. Pfizer Recent Development Table 121. Roche Company Information Table 122. Roche Business Overview Table 123. Roche EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Roche EGFR-TKI Product Portfolio Table 125. Roche Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Teva EGFR-TKI Product Portfolio Table 130. Teva Recent Development Table 131. Yuhan Corporation Company Information Table 132. Yuhan Corporation Business Overview Table 133. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Yuhan Corporation EGFR-TKI Product Portfolio Table 135. Yuhan Corporation Recent Development Table 136. Betta Pharma Company Information Table 137. Betta Pharma Business Overview Table 138. Betta Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Betta Pharma EGFR-TKI Product Portfolio Table 140. Betta Pharma Recent Development Table 141. Chengdu Brilliant Pharmaceuticals Company Information Table 142. Chengdu Brilliant Pharmaceuticals Business Overview Table 143. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio Table 145. Chengdu Brilliant Pharmaceuticals Recent Development Table 146. Hansoh Pharma Company Information Table 147. Hansoh Pharma Business Overview Table 148. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Hansoh Pharma EGFR-TKI Product Portfolio Table 150. Hansoh Pharma Recent Development Table 151. Shanghai Allist Pharmaceuticals Company Information Table 152. Shanghai Allist Pharmaceuticals Business Overview Table 153. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio Table 155. Shanghai Allist Pharmaceuticals Recent Development Table 156. Wanbang Biopharmaceuticals Company Information Table 157. Wanbang Biopharmaceuticals Business Overview Table 158. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio Table 160. Wanbang Biopharmaceuticals Recent Development Table 161. North America EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 162. North America EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 163. North America EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 164. North America EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 165. North America EGFR-TKI Sales Price by Type (2021-2026) & (US$/Unit) Table 166. North America EGFR-TKI Sales Price by Type (2027-2032) & (US$/Unit) Table 167. North America EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 168. North America EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 169. North America EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 170. North America EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 171. North America EGFR-TKI Sales Price by Application (2021-2026) & (US$/Unit) Table 172. North America EGFR-TKI Sales Price by Application (2027-2032) & (US$/Unit) Table 173. North America EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America EGFR-TKI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. North America EGFR-TKI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. North America EGFR-TKI Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. North America EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 178. North America EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 179. North America EGFR-TKI Sales Price by Country (2021-2026) & (US$/Unit) Table 180. North America EGFR-TKI Sales Price by Country (2027-2032) & (US$/Unit) Table 181. United States EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 182. Canada EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 183. Mexico EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 184. Europe EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 185. Europe EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 186. Europe EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 187. Europe EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 188. Europe EGFR-TKI Sales Price by Type (2021-2026) & (US$/Unit) Table 189. Europe EGFR-TKI Sales Price by Type (2027-2032) & (US$/Unit) Table 190. Europe EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 191. Europe EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 192. Europe EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 193. Europe EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 194. Europe EGFR-TKI Sales Price by Application (2021-2026) & (US$/Unit) Table 195. Europe EGFR-TKI Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Europe EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Europe EGFR-TKI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Europe EGFR-TKI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Europe EGFR-TKI Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. Europe EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 201. Europe EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 202. Europe EGFR-TKI Sales Price by Country (2021-2026) & (US$/Unit) Table 203. Europe EGFR-TKI Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Germany EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 205. France EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 206. U.K. EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 207. Italy EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 208. Russia EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 209. Spain EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 210. Netherlands EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 211. Switzerland EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 212. Sweden EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 213. Poland EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 214. China EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 215. China EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 216. China EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 217. China EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 218. China EGFR-TKI Sales Price by Type (2021-2026) & (US$/Unit) Table 219. China EGFR-TKI Sales Price by Type (2027-2032) & (US$/Unit) Table 220. China EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 221. China EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 222. China EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 223. China EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 224. China EGFR-TKI Sales Price by Application (2021-2026) & (US$/Unit) Table 225. China EGFR-TKI Sales Price by Application (2027-2032) & (US$/Unit) Table 226. Asia EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 227. Asia EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 228. Asia EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 229. Asia EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 230. Asia EGFR-TKI Sales Price by Type (2021-2026) & (US$/Unit) Table 231. Asia EGFR-TKI Sales Price by Type (2027-2032) & (US$/Unit) Table 232. Asia EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 233. Asia EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 234. Asia EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 235. Asia EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 236. Asia EGFR-TKI Sales Price by Application (2021-2026) & (US$/Unit) Table 237. Asia EGFR-TKI Sales Price by Application (2027-2032) & (US$/Unit) Table 238. Asia EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. Asia EGFR-TKI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. Asia EGFR-TKI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. Asia EGFR-TKI Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 242. Asia EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 243. Asia EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 244. Asia EGFR-TKI Sales Price by Country (2021-2026) & (US$/Unit) Table 245. Asia EGFR-TKI Sales Price by Country (2027-2032) & (US$/Unit) Table 246. Japan EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 247. South Korea EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 248. India EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 249. Australia EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 250. Taiwan EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 251. Southeast Asia EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 252. SAMEA EGFR-TKI Revenue by Type (2021-2026) & (US$ Million) Table 253. SAMEA EGFR-TKI Revenue by Type (2027-2032) & (US$ Million) Table 254. SAMEA EGFR-TKI Sales by Type (2021-2026) & (K Units) Table 255. SAMEA EGFR-TKI Sales by Type (2027-2032) & (K Units) Table 256. SAMEA EGFR-TKI Sales Price by Type (2021-2026) & (US$/Unit) Table 257. SAMEA EGFR-TKI Sales Price by Type (2027-2032) & (US$/Unit) Table 258. SAMEA EGFR-TKI Revenue by Application (2021-2026) & (US$ Million) Table 259. SAMEA EGFR-TKI Revenue by Application (2027-2032) & (US$ Million) Table 260. SAMEA EGFR-TKI Sales by Application (2021-2026) & (K Units) Table 261. SAMEA EGFR-TKI Sales by Application (2027-2032) & (K Units) Table 262. SAMEA EGFR-TKI Sales Price by Application (2021-2026) & (US$/Unit) Table 263. SAMEA EGFR-TKI Sales Price by Application (2027-2032) & (US$/Unit) Table 264. SAMEA EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 265. SAMEA EGFR-TKI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 266. SAMEA EGFR-TKI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 267. SAMEA EGFR-TKI Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 268. SAMEA EGFR-TKI Sales by Country (2021-2026) & (K Units) Table 269. SAMEA EGFR-TKI Sales by Country (2027-2032) & (K Units) Table 270. SAMEA EGFR-TKI Sales Price by Country (2021-2026) & (US$/Unit) Table 271. SAMEA EGFR-TKI Sales Price by Country (2027-2032) & (US$/Unit) Table 272. Brazil EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 273. Argentina EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 274. Chile EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 275. Colombia EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 276. Peru EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 277. Saudi Arabia EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 278. Israel EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 279. UAE EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 280. Turkey EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 281. Iran EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 282. Egypt EGFR-TKI Revenue (2021-2032) & (US$ Million) Table 283. Key Raw Materials Table 284. Raw Materials Key Suppliers Table 285. EGFR-TKI Distributors List Table 286. EGFR-TKI Customers List Table 287. Research Programs/Design for This Report Table 288. Authors List of This Report Table 289. Secondary Sources Table 290. Primary Sources List of Figures Figure 1. EGFR-TKI Image Figure 2. Global EGFR-TKI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EGFR-TKI Market Size Share 2021 VS 2025 VS 2032 Figure 4. Afatinib Image Figure 5. Aumolertinib Image Figure 6. Icotinib Image Figure 7. Osimertinib Image Figure 8. Dacomitinib Image Figure 9. Erlotinib Image Figure 10. Furmonertinib Image Figure 11. Gefitinib Image Figure 12. Lazertinib Image Figure 13. Other Image Figure 14. Global EGFR-TKI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global EGFR-TKI Market Size Share 2021 VS 2025 VS 2032 Figure 16. Segment by Application Image Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global EGFR-TKI Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global EGFR-TKI Revenue (2021-2032) & (US$ Million) Figure 22. Global EGFR-TKI Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global EGFR-TKI Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global EGFR-TKI Revenue Market Share by Region (2021-2032) Figure 25. Global EGFR-TKI Sales (2021-2032) & (K Units) Figure 26. Global EGFR-TKI Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global EGFR-TKI Sales Market Share by Region (2021-2032) Figure 28. US & Canada & Mexico EGFR-TKI Sales YoY (2021-2032) & (K Units) Figure 29. Europe EGFR-TKI Sales YoY (2021-2032) & (K Units) Figure 30. China EGFR-TKI Sales YoY (2021-2032) & (K Units) Figure 31. Asia (Excluding China) EGFR-TKI Sales YoY (2021-2032) & (K Units) Figure 32. South America, Middle East and Africa EGFR-TKI Sales YoY (2021-2032) & (K Units) Figure 33. Global EGFR-TKI Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global EGFR-TKI Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global EGFR-TKI Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global EGFR-TKI Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global EGFR-TKI Revenue Market Share by Type (2021-2032) Figure 39. Global EGFR-TKI Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global EGFR-TKI Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 41. Global EGFR-TKI Sales Market Share by Type (2021-2032) Figure 42. Global EGFR-TKI Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 43. Global EGFR-TKI Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global EGFR-TKI Revenue Market Share by Application (2021-2032) Figure 45. Global EGFR-TKI Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 46. Global EGFR-TKI Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 47. Global EGFR-TKI Sales Market Share by Application (2021-2032) Figure 48. North America EGFR-TKI Revenue Share by Type (2021-2032) Figure 49. North America EGFR-TKI Sales Share by Type (2021-2032) Figure 50. North America EGFR-TKI Revenue Share by Application (2021-2032) Figure 51. North America EGFR-TKI Sales Share by Application (2021-2032) Figure 52. North America EGFR-TKI Revenue Share by Country (2021-2032) Figure 53. North America EGFR-TKI Sales Share by Country (2021-2032) Figure 54. Europe EGFR-TKI Revenue Share by Type (2021-2032) Figure 55. Europe EGFR-TKI Sales Share by Type (2021-2032) Figure 56. Europe EGFR-TKI Revenue Share by Application (2021-2032) Figure 57. Europe EGFR-TKI Sales Share by Application (2021-2032) Figure 58. Europe EGFR-TKI Revenue Share by Country (2021-2032) Figure 59. Europe EGFR-TKI Sales Share by Country (2021-2032) Figure 60. China EGFR-TKI Revenue Share by Type (2021-2032) Figure 61. China EGFR-TKI Sales Share by Type (2021-2032) Figure 62. China EGFR-TKI Revenue Share by Application (2021-2032) Figure 63. China EGFR-TKI Sales Share by Application (2021-2032) Figure 64. Asia EGFR-TKI Revenue Share by Type (2021-2032) Figure 65. Asia EGFR-TKI Sales Share by Type (2021-2032) Figure 66. Asia EGFR-TKI Revenue Share by Application (2021-2032) Figure 67. Asia EGFR-TKI Sales Share by Application (2021-2032) Figure 68. Asia EGFR-TKI Revenue Share by Country (2021-2032) Figure 69. Asia EGFR-TKI Sales Share by Country (2021-2032) Figure 70. SAMEA EGFR-TKI Revenue Share by Type (2021-2032) Figure 71. SAMEA EGFR-TKI Sales Share by Type (2021-2032) Figure 72. SAMEA EGFR-TKI Revenue Share by Application (2021-2032) Figure 73. SAMEA EGFR-TKI Sales Share by Application (2021-2032) Figure 74. SAMEA EGFR-TKI Revenue Share by Country (2021-2032) Figure 75. SAMEA EGFR-TKI Sales Share by Country (2021-2032) Figure 76. EGFR-TKI Value Chain Figure 77. Manufacturing Cost Structure Figure 78. EGFR-TKI Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Afatinib
  • Aumolertinib
  • Icotinib
  • Osimertinib
  • Dacomitinib
  • Erlotinib
  • Furmonertinib
  • Gefitinib
  • Lazertinib
  • Other
Applications
  • Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • ArriVent Biopharma
  • AstraZeneca
  • Beacon Pharma
  • Boehringer Ingelheim Pharmaceuticals
  • Cipla
  • Drug International
  • Glenmark Pharmaceuticals
  • Hanmi Pharmaceutical
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Roche
  • Teva
  • Yuhan Corporation
  • Betta Pharma
  • Chengdu Brilliant Pharmaceuticals
  • Hansoh Pharma
  • Shanghai Allist Pharmaceuticals
  • Wanbang Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 EGFR-TKI Market by Type
  3. 1.2.1 Global EGFR-TKI Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Afatinib
  5. 1.2.3 Aumolertinib
  6. 1.2.4 Icotinib
  7. 1.2.5 Osimertinib
  8. 1.2.6 Dacomitinib
  9. 1.2.7 Erlotinib
  10. 1.2.8 Furmonertinib
  11. 1.2.9 Gefitinib
  12. 1.2.10 Lazertinib
  13. 1.2.11 Other
  14. 1.3 EGFR-TKI Market by Application
  15. 1.3.1 Global EGFR-TKI Market Size by Application, 2021 VS 2025 VS 2032
  16. 1.3.2 Segment by Application
  17. 1.3.3 Hospital and Clinic
  18. 1.3.4 Retail Pharmacies
  19. 1.3.5 Other
  20. 1.4 Assumptions and Limitations
  21. 1.5 Study Goals and Objectives
2 EGFR-TKI Market Dynamics
  1. 2.1 EGFR-TKI Industry Trends
  2. 2.2 EGFR-TKI Industry Drivers
  3. 2.3 EGFR-TKI Industry Opportunities and Challenges
  4. 2.4 EGFR-TKI Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global EGFR-TKI Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global EGFR-TKI Revenue by Region
  3. 3.2.1 Global EGFR-TKI Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global EGFR-TKI Revenue by Region (2021-2026)
  5. 3.2.3 Global EGFR-TKI Revenue by Region (2027-2032)
  6. 3.2.4 Global EGFR-TKI Revenue Market Share by Region (2021-2032)
  7. 3.3 Global EGFR-TKI Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global EGFR-TKI Sales by Region
  9. 3.4.1 Global EGFR-TKI Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global EGFR-TKI Sales by Region (2021-2026)
  11. 3.4.3 Global EGFR-TKI Sales by Region (2027-2032)
  12. 3.4.4 Global EGFR-TKI Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global EGFR-TKI Revenue by Manufacturers
  2. 4.1.1 Global EGFR-TKI Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global EGFR-TKI Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global EGFR-TKI Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global EGFR-TKI Sales by Manufacturers
  6. 4.2.1 Global EGFR-TKI Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global EGFR-TKI Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global EGFR-TKI Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global EGFR-TKI Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global EGFR-TKI Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global EGFR-TKI Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global EGFR-TKI Manufacturers, Product Type & Application
  13. 4.7 Global EGFR-TKI Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global EGFR-TKI Market CR5 and HHI
  16. 4.8.2 2025 EGFR-TKI Tier 1, Tier 2, and Tier 3
5 EGFR-TKI Market by Type
  1. 5.1 Global EGFR-TKI Revenue by Type
  2. 5.1.1 Global EGFR-TKI Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global EGFR-TKI Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global EGFR-TKI Revenue Market Share by Type (2021-2032)
  5. 5.2 Global EGFR-TKI Sales by Type
  6. 5.2.1 Global EGFR-TKI Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global EGFR-TKI Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global EGFR-TKI Sales Market Share by Type (2021-2032)
  9. 5.3 Global EGFR-TKI Price by Type
6 EGFR-TKI Market by Application
  1. 6.1 Global EGFR-TKI Revenue by Application
  2. 6.1.1 Global EGFR-TKI Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global EGFR-TKI Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global EGFR-TKI Revenue Market Share by Application (2021-2032)
  5. 6.2 Global EGFR-TKI Sales by Application
  6. 6.2.1 Global EGFR-TKI Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global EGFR-TKI Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global EGFR-TKI Sales Market Share by Application (2021-2032)
  9. 6.3 Global EGFR-TKI Price by Application
7 Company Profiles
  1. 7.1 ArriVent Biopharma
  2. 7.1.1 ArriVent Biopharma Company Information
  3. 7.1.2 ArriVent Biopharma Business Overview
  4. 7.1.3 ArriVent Biopharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ArriVent Biopharma EGFR-TKI Product Portfolio
  6. 7.1.5 ArriVent Biopharma Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca EGFR-TKI Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Beacon Pharma
  14. 7.3.1 Beacon Pharma Company Information
  15. 7.3.2 Beacon Pharma Business Overview
  16. 7.3.3 Beacon Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beacon Pharma EGFR-TKI Product Portfolio
  18. 7.3.5 Beacon Pharma Recent Developments
  19. 7.4 Boehringer Ingelheim Pharmaceuticals
  20. 7.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
  21. 7.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  22. 7.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio
  24. 7.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  25. 7.5 Cipla
  26. 7.5.1 Cipla Company Information
  27. 7.5.2 Cipla Business Overview
  28. 7.5.3 Cipla EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cipla EGFR-TKI Product Portfolio
  30. 7.5.5 Cipla Recent Developments
  31. 7.6 Drug International
  32. 7.6.1 Drug International Company Information
  33. 7.6.2 Drug International Business Overview
  34. 7.6.3 Drug International EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Drug International EGFR-TKI Product Portfolio
  36. 7.6.5 Drug International Recent Developments
  37. 7.7 Glenmark Pharmaceuticals
  38. 7.7.1 Glenmark Pharmaceuticals Company Information
  39. 7.7.2 Glenmark Pharmaceuticals Business Overview
  40. 7.7.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Glenmark Pharmaceuticals EGFR-TKI Product Portfolio
  42. 7.7.5 Glenmark Pharmaceuticals Recent Developments
  43. 7.8 Hanmi Pharmaceutical
  44. 7.8.1 Hanmi Pharmaceutical Company Information
  45. 7.8.2 Hanmi Pharmaceutical Business Overview
  46. 7.8.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hanmi Pharmaceutical EGFR-TKI Product Portfolio
  48. 7.8.5 Hanmi Pharmaceutical Recent Developments
  49. 7.9 Johnson & Johnson
  50. 7.9.1 Johnson & Johnson Company Information
  51. 7.9.2 Johnson & Johnson Business Overview
  52. 7.9.3 Johnson & Johnson EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Johnson & Johnson EGFR-TKI Product Portfolio
  54. 7.9.5 Johnson & Johnson Recent Developments
  55. 7.10 Mylan
  56. 7.10.1 Mylan Company Information
  57. 7.10.2 Mylan Business Overview
  58. 7.10.3 Mylan EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mylan EGFR-TKI Product Portfolio
  60. 7.10.5 Mylan Recent Developments
  61. 7.11 Pfizer
  62. 7.11.1 Pfizer Company Information
  63. 7.11.2 Pfizer Business Overview
  64. 7.11.3 Pfizer EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pfizer EGFR-TKI Product Portfolio
  66. 7.11.5 Pfizer Recent Developments
  67. 7.12 Roche
  68. 7.12.1 Roche Company Information
  69. 7.12.2 Roche Business Overview
  70. 7.12.3 Roche EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Roche EGFR-TKI Product Portfolio
  72. 7.12.5 Roche Recent Developments
  73. 7.13 Teva
  74. 7.13.1 Teva Company Information
  75. 7.13.2 Teva Business Overview
  76. 7.13.3 Teva EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Teva EGFR-TKI Product Portfolio
  78. 7.13.5 Teva Recent Developments
  79. 7.14 Yuhan Corporation
  80. 7.14.1 Yuhan Corporation Company Information
  81. 7.14.2 Yuhan Corporation Business Overview
  82. 7.14.3 Yuhan Corporation EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Yuhan Corporation EGFR-TKI Product Portfolio
  84. 7.14.5 Yuhan Corporation Recent Developments
  85. 7.15 Betta Pharma
  86. 7.15.1 Betta Pharma Company Information
  87. 7.15.2 Betta Pharma Business Overview
  88. 7.15.3 Betta Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Betta Pharma EGFR-TKI Product Portfolio
  90. 7.15.5 Betta Pharma Recent Developments
  91. 7.16 Chengdu Brilliant Pharmaceuticals
  92. 7.16.1 Chengdu Brilliant Pharmaceuticals Company Information
  93. 7.16.2 Chengdu Brilliant Pharmaceuticals Business Overview
  94. 7.16.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio
  96. 7.16.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  97. 7.17 Hansoh Pharma
  98. 7.17.1 Hansoh Pharma Company Information
  99. 7.17.2 Hansoh Pharma Business Overview
  100. 7.17.3 Hansoh Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Hansoh Pharma EGFR-TKI Product Portfolio
  102. 7.17.5 Hansoh Pharma Recent Developments
  103. 7.18 Shanghai Allist Pharmaceuticals
  104. 7.18.1 Shanghai Allist Pharmaceuticals Company Information
  105. 7.18.2 Shanghai Allist Pharmaceuticals Business Overview
  106. 7.18.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio
  108. 7.18.5 Shanghai Allist Pharmaceuticals Recent Developments
  109. 7.19 Wanbang Biopharmaceuticals
  110. 7.19.1 Wanbang Biopharmaceuticals Company Information
  111. 7.19.2 Wanbang Biopharmaceuticals Business Overview
  112. 7.19.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio
  114. 7.19.5 Wanbang Biopharmaceuticals Recent Developments
8 North America
  1. 8.1 North America EGFR-TKI Market Size by Type
  2. 8.1.1 North America EGFR-TKI Revenue by Type (2021-2032)
  3. 8.1.2 North America EGFR-TKI Sales by Type (2021-2032)
  4. 8.1.3 North America EGFR-TKI Price by Type (2021-2032)
  5. 8.2 North America EGFR-TKI Market Size by Application
  6. 8.2.1 North America EGFR-TKI Revenue by Application (2021-2032)
  7. 8.2.2 North America EGFR-TKI Sales by Application (2021-2032)
  8. 8.2.3 North America EGFR-TKI Price by Application (2021-2032)
  9. 8.3 North America EGFR-TKI Market Size by Country
  10. 8.3.1 North America EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America EGFR-TKI Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America EGFR-TKI Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe EGFR-TKI Market Size by Type
  2. 9.1.1 Europe EGFR-TKI Revenue by Type (2021-2032)
  3. 9.1.2 Europe EGFR-TKI Sales by Type (2021-2032)
  4. 9.1.3 Europe EGFR-TKI Price by Type (2021-2032)
  5. 9.2 Europe EGFR-TKI Market Size by Application
  6. 9.2.1 Europe EGFR-TKI Revenue by Application (2021-2032)
  7. 9.2.2 Europe EGFR-TKI Sales by Application (2021-2032)
  8. 9.2.3 Europe EGFR-TKI Price by Application (2021-2032)
  9. 9.3 Europe EGFR-TKI Market Size by Country
  10. 9.3.1 Europe EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe EGFR-TKI Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe EGFR-TKI Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China EGFR-TKI Market Size by Type
  2. 10.1.1 China EGFR-TKI Revenue by Type (2021-2032)
  3. 10.1.2 China EGFR-TKI Sales by Type (2021-2032)
  4. 10.1.3 China EGFR-TKI Price by Type (2021-2032)
  5. 10.2 China EGFR-TKI Market Size by Application
  6. 10.2.1 China EGFR-TKI Revenue by Application (2021-2032)
  7. 10.2.2 China EGFR-TKI Sales by Application (2021-2032)
  8. 10.2.3 China EGFR-TKI Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia EGFR-TKI Market Size by Type
  2. 11.1.1 Asia EGFR-TKI Revenue by Type (2021-2032)
  3. 11.1.2 Asia EGFR-TKI Sales by Type (2021-2032)
  4. 11.1.3 Asia EGFR-TKI Price by Type (2021-2032)
  5. 11.2 Asia EGFR-TKI Market Size by Application
  6. 11.2.1 Asia EGFR-TKI Revenue by Application (2021-2032)
  7. 11.2.2 Asia EGFR-TKI Sales by Application (2021-2032)
  8. 11.2.3 Asia EGFR-TKI Price by Application (2021-2032)
  9. 11.3 Asia EGFR-TKI Market Size by Country
  10. 11.3.1 Asia EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia EGFR-TKI Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia EGFR-TKI Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA EGFR-TKI Market Size by Type
  2. 12.1.1 SAMEA EGFR-TKI Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA EGFR-TKI Sales by Type (2021-2032)
  4. 12.1.3 SAMEA EGFR-TKI Price by Type (2021-2032)
  5. 12.2 SAMEA EGFR-TKI Market Size by Application
  6. 12.2.1 SAMEA EGFR-TKI Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA EGFR-TKI Sales by Application (2021-2032)
  8. 12.2.3 SAMEA EGFR-TKI Price by Application (2021-2032)
  9. 12.3 SAMEA EGFR-TKI Market Size by Country
  10. 12.3.1 SAMEA EGFR-TKI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA EGFR-TKI Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA EGFR-TKI Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 EGFR-TKI Value Chain Analysis
  2. 13.1.1 EGFR-TKI Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 EGFR-TKI Production Mode & Process
  6. 13.2 EGFR-TKI Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 EGFR-TKI Distributors
  9. 13.2.3 EGFR-TKI Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst